FOLFOX / Bevacizumab (Beva) +/- Irinotecan in advanced colorectal cancer (CRC): A randomized phase II trial (AIO KRK 0209, CHARTA)
H.-J. Schmoll,Benjamin Garlipp,Christian Junghanß, Malte Leithäuser,Arndt Vogel, M. Schaefers,Ulrich Kaiser,Heinz-Gert Hoeffkes,Axel Florschütz,J. Ruessel,Stephan Kanzler,Thomas Edelmann,Helmut Forstbauer,Thomas Göhler,Carla Hannig,Bert Hildebrandt,Jörg Steighardt,Fabian Maximilian Meinert,Franziska Cygon,Alexander Stein ANNALS OF ONCOLOGY（2016）
AI 理解论文
溯源树
样例
